EV-D68, Acute Flaccid Myelitis Outbreaks Smaller Than Expected
Sizes of the outbreaks in the U.S. in 2020 likely reduced by nonpharmaceutical interventions related to COVID-19, such as social distancing
ChAdOx1 nCoV-19 Vaccine Does Not Protect Against B.1.351 SARS-CoV-2 Variant
Vaccine efficacy was 10.4 percent against the B.1.351 variant of SARS-CoV-2, first described in South Africa
Broadly Neutralizing Antibodies Do Not Prevent Overall HIV-1 Acquisition
Analysis of pooled data from proof-of-concept trials shows bnAb VRC01 does reduce incidence of infection with VRC01-sensitive isolates
AstraZeneca Vaccine Safe and Effective, European Medicines Agency Says
Officials hope announcement will ease concerns about possible rare side effects involving blood clots
Florida Baby First in U.S. Born With COVID-19 Antibodies
Mother received her first shot of the Moderna COVID-19 vaccine when she was 36 weeks pregnant
Skin Rashes Occur in Considerable Number of SARS-CoV-2 Cases
17 percent of SARS-CoV-2-positive cases reported skin rash as first presentation; 21 percent had skin rash as only clinical sign
Incidence of Scleritis Down in the United Kingdom
Patients with scleritis have increased risk for prior diagnosis of infectious/immune-mediated inflammatory disease
Aspirin Use Tied to Lower Rates of COVID-19 Infection
Adults using low-dose aspirin for primary or secondary prevention of CVD had lower likelihood of COVID-19 infection versus nonusers
ASA: Endocarditis, Related Strokes Up During Opioid Epidemic
Authors say known IV drug users who have infective endocarditis should be screened carefully for symptoms of cardiovascular disease
Most People Complete Two-Dose COVID-19 Vaccination Series
Of those receiving a second COVID-19 vaccine dose, 95.6 percent did so within the recommended interval
